Literature DB >> 20623281

Plasma and drainage fluid levels of soluble receptor activator of nuclear factor-kB (sRANK), soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) during proximal humerus fracture healing.

Alessandra Colombini1, Giovanni Lombardi, Emanuela Galliera, Giada Dogliotti, Pietro Randelli, Alexander Meerssemann, Giuseppe Mineo, Paolo Cabitza, Massimiliano Marco Corsi.   

Abstract

Fracture healing is an ordered process that restores the structural integrity of the bone. Soluble receptor activator of nuclear factor-kB (sRANK), its ligand (sRANKL) and osteoprotegerin (OPG) are involved in bone remodelling, thus they may play a role in fracture repair. OPG, soluble RANK and RANKL levels were measured in plasma and in drainage fluid, collected from pre-surgery phase to healing in ten patients of both genders (age range 26-65 years) with proximal humerus fracture needing osteosynthesis. All patients showed fracture healing. No significant modifications in the concentrations of sRANKL and OPG were observed, while sRANK showed a significant increase in drainage fluid 24 hours post-surgery compared with intra-surgery time. OPG levels were higher in plasma and drainage fluid than sRANK and sRANKL at each time point. Since there are no published data about sRANK involvement in fracture healing, our study represents the first preliminary indication about a local increase of this marker concentration immediately after surgery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20623281      PMCID: PMC3080502          DOI: 10.1007/s00264-010-1088-3

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  19 in total

Review 1.  Osteoprotegerin ligand: a regulator of immune responses and bone physiology.

Authors:  Y Y Kong; W J Boyle; J M Penninger
Journal:  Immunol Today       Date:  2000-10

Review 2.  Clinical review 114: hot topic. The role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases.

Authors:  L C Hofbauer; A E Heufelder
Journal:  J Clin Endocrinol Metab       Date:  2000-07       Impact factor: 5.958

3.  Serum measurement of osteoprotegerin--clinical relevance and potential applications.

Authors:  L C Hofbauer; M Schoppet
Journal:  Eur J Endocrinol       Date:  2001-12       Impact factor: 6.664

Review 4.  Evaluation and management of valgus impacted four-part proximal humerus fractures.

Authors:  Michael J DeFranco; John J Brems; Gerald R Williams; Joseph P Iannotti
Journal:  Clin Orthop Relat Res       Date:  2006-01       Impact factor: 4.176

5.  Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.

Authors:  T Kon; T J Cho; T Aizawa; M Yamazaki; N Nooh; D Graves; L C Gerstenfeld; T A Einhorn
Journal:  J Bone Miner Res       Date:  2001-06       Impact factor: 6.741

6.  Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells.

Authors:  U M Malyankar; M Scatena; K L Suchland; T J Yun; E A Clark; C M Giachelli
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

7.  The epidemiology of proximal humeral fractures.

Authors:  C M Court-Brown; A Garg; M M McQueen
Journal:  Acta Orthop Scand       Date:  2001-08

8.  A minimally invasive approach for plate fixation of the proximal humerus.

Authors:  Michael J Gardner; Matthew H Griffith; Joshua S Dines; Dean G Lorich
Journal:  Bull Hosp Jt Dis       Date:  2004

9.  OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40.

Authors:  T J Yun; P M Chaudhary; G L Shu; J K Frazer; M K Ewings; S M Schwartz; V Pascual; L E Hood; E A Clark
Journal:  J Immunol       Date:  1998-12-01       Impact factor: 5.422

Review 10.  Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.

Authors:  Ann E Kearns; Sundeep Khosla; Paul J Kostenuik
Journal:  Endocr Rev       Date:  2007-12-05       Impact factor: 19.871

View more
  3 in total

1.  Increased expression of receptor activator of nuclear factor-κB ligand in osteoblasts from adolescent idiopathic scoliosis patients with low bone mineral density.

Authors:  Song Zhou; Weijun Wang; Zezhang Zhu; Xu Sun; Feng Zhu; Yang Yu; Bangping Qian; Bin Wang; Gang Yin; Yong Qiu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-10-18

2.  Interplay between low plasma RANKL and VDR-FokI polymorphism in lumbar disc herniation independently from age, body mass, and environmental factors: a case-control study in the Italian population.

Authors:  Veronica Sansoni; Silvia Perego; Alessandra Colombini; Giuseppe Banfi; Marco Brayda-Bruno; Giovanni Lombardi
Journal:  Eur Spine J       Date:  2015-08-11       Impact factor: 3.134

3.  The Effect of Orthognathic Surgery on Osteoprotegerin as Immunological Caliper of Bone Healing.

Authors:  Sara Soliman; Mamdouh Ahmed
Journal:  Open Access Maced J Med Sci       Date:  2016-11-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.